DX in 2020 with Stage 4 PCa and have done full course of Chemo treatment. Have been on Abiraterone for over 18 month but now it seems to be failing as PSA is continually rising; now 18 (was 2.39 back in April 2022) . I'm now mCRPC and still taking Abiraterone, ADT and Zometa.
Signed up for new trial sponsored by Bayer Co. Some participants will get course of Radium223 others will get course of Enzalutamide. Just found out I have been assigned to the Radium223 group
I have some bone mets (pelvic and L3 area) but no bone pain. Is the Radium223 treatment a good option for me now or should I consider another treatment options.?
All comments welcomed.